Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Nursing (11)
- Health and Medical Administration (4)
- Life Sciences (4)
- Behavioral Medicine (2)
- Cardiology (2)
-
- Gastroenterology (2)
- Genetics and Genomics (2)
- Medical Education (2)
- Medical Sciences (2)
- Obstetrics and Gynecology (2)
- Pediatrics (2)
- Bioethics and Medical Ethics (1)
- Biomedical Devices and Instrumentation (1)
- Biomedical Engineering and Bioengineering (1)
- COVID-19 (1)
- Community Health and Preventive Medicine (1)
- Engineering (1)
- Health Information Technology (1)
- Health Services Research (1)
- Hematology (1)
- Immunology and Infectious Disease (1)
- Library and Information Science (1)
- Maternal, Child Health and Neonatal Nursing (1)
- Medical Microbiology (1)
- Mental and Social Health (1)
- Microbiology (1)
- Neurology (1)
- Keyword
-
- 2019-nCoV (9)
- Covid-19 (8)
- Humans (6)
- Covenant (4)
- Texas (4)
-
- California (3)
- Oregon (3)
- Portland (3)
- Spokane (3)
- Washington (3)
- Adult (2)
- Animals (2)
- Cards (2)
- Cell Line (2)
- Female (2)
- HIV (2)
- Holy family (2)
- Host-Pathogen Interactions (2)
- Lubbock (2)
- Malaria (2)
- Male (2)
- Mice (2)
- Middle Aged (2)
- Ppmc (2)
- RNA, Viral (2)
- Toxoplasma (2)
- Virus Replication (2)
- AIDS (1)
- Adaptor Proteins, Vesicular Transport (1)
- Adolescent (1)
- File Type
Articles 31 - 33 of 33
Full-Text Articles in Infectious Disease
A Novel Agonist Of The Trif Pathway Induces A Cellular State Refractory To Replication Of Zika, Chikungunya, And Dengue Viruses., Kara M Pryke, Jinu Abraham, Tina M Sali, Bryan J Gall, Iris Archer, Andrew Liu, Shelly Bambina, Jason R Baird, Michael J. Gough, Marita Chakhtoura, Elias K Haddad, Ilsa T Kirby, Aaron Nilsen, Daniel N Streblow, Alec J Hirsch, Jessica L Smith, Victor R Defilippis
A Novel Agonist Of The Trif Pathway Induces A Cellular State Refractory To Replication Of Zika, Chikungunya, And Dengue Viruses., Kara M Pryke, Jinu Abraham, Tina M Sali, Bryan J Gall, Iris Archer, Andrew Liu, Shelly Bambina, Jason R Baird, Michael J. Gough, Marita Chakhtoura, Elias K Haddad, Ilsa T Kirby, Aaron Nilsen, Daniel N Streblow, Alec J Hirsch, Jessica L Smith, Victor R Defilippis
Articles, Abstracts, and Reports
The ongoing concurrent outbreaks of Zika, Chikungunya, and dengue viruses in Latin America and the Caribbean highlight the need for development of broad-spectrum antiviral treatments. The type I interferon (IFN) system has evolved in vertebrates to generate tissue responses that actively block replication of multiple known and potentially zoonotic viruses. As such, its control and activation through pharmacological agents may represent a novel therapeutic strategy for simultaneously impairing growth of multiple virus types and rendering host populations resistant to virus spread. In light of this strategy's potential, we undertook a screen to identify novel interferon-activating small molecules. Here, we describe …
Longitudinal Peripheral Blood Transcriptional Analysis Of A Patient With Severe Ebola Virus Disease., John C Kash, Kathie-Anne Walters, Jason Kindrachuk, David Baxter, Kelsey Scherler, Krisztina B Janosko, Rick D Adams, Andrew S Herbert, Rebekah M James, Spencer W Stonier, Matthew J Memoli, John M Dye, Richard T Davey, Daniel S Chertow, Jeffery K Taubenberger
Longitudinal Peripheral Blood Transcriptional Analysis Of A Patient With Severe Ebola Virus Disease., John C Kash, Kathie-Anne Walters, Jason Kindrachuk, David Baxter, Kelsey Scherler, Krisztina B Janosko, Rick D Adams, Andrew S Herbert, Rebekah M James, Spencer W Stonier, Matthew J Memoli, John M Dye, Richard T Davey, Daniel S Chertow, Jeffery K Taubenberger
Articles, Abstracts, and Reports
The 2013-2015 outbreak of Ebola virus disease in Guinea, Liberia, and Sierra Leone was unprecedented in the number of documented cases, but there have been few published reports on immune responses in clinical cases and their relationships with the course of illness and severity of Ebola virus disease. Symptoms of Ebola virus disease can include severe headache, myalgia, asthenia, fever, fatigue, diarrhea, vomiting, abdominal pain, and hemorrhage. Although experimental treatments are in development, there are no current U.S. Food and Drug Administration-approved vaccines or therapies. We report a detailed study of host gene expression as measured by microarray in daily …
The Promise Of Systems Biology Approaches For Revealing Host Pathogen Interactions In Malaria., Meghan Zuck, Laura S Austin, Samuel A Danziger, John D Aitchison, Alexis Kaushansky
The Promise Of Systems Biology Approaches For Revealing Host Pathogen Interactions In Malaria., Meghan Zuck, Laura S Austin, Samuel A Danziger, John D Aitchison, Alexis Kaushansky
Articles, Abstracts, and Reports
Despite global eradication efforts over the past century, malaria remains a devastating public health burden, causing almost half a million deaths annually (WHO, 2016). A detailed understanding of the mechanisms that control malaria infection has been hindered by technical challenges of studying a complex parasite life cycle in multiple hosts. While many interventions targeting the parasite have been implemented, the complex biology of